This website is part of the ECDC (European Centre for Disease Prevention and Control) network

Antimicrobial Resistance and Healthcare-associated Infections Programme

The programme on Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) covers two major public health issues:



The ARHAI programme focuses on 4 areas of public health: surveillance, response and scientific advice, training and communication to address the threat of antimicrobial resistance and healthcare-associated infections.

Read more about the programme




Patient safety: greater efforts needed to prevent healthcare-associated infections

A patient safety package was published by the European Commission on 19 June 2014. It includes a new report from the Commission on the implementation of the Council Recommendation on patient safety, including the prevention and control healthcare-associated infections (2009/C 151/01). This report concludes that greater efforts are needed, in particular to ensure adequate numbers of specialised infection control staff in healthcare settings and sufficient capacity for patient isolation.






Antimicrobial resistance

Antibiotics have revolutionised the way we treat patients with bacterial infections. But they have also been liable to misuse.

Healthcare-associated infections

Approximately 4 100 000 patients are estimated to acquire a healthcare-associated infection in EU every year.



Occurrence and spread of antimicrobial resistance in Europe.

Antimicrobial consumption interactive database (ESAC-Net)

Antimicrobial consumption, in the community and the hospital sector in Europe.

Point prevalence survey interactive database (HAI-Net PPS)

Healthcare-associated infections and antimicrobial use in acute ​​care hospitals.



​ECDC held its second meeting of the Antimicrobial Resistance and Healthcare-associated Infections (ARHAI) Networks on 26-28 November 2012, in Berlin, Germany. See the conference presentations


© European Centre for Disease Prevention and Control (ECDC) 2005 - 2014